Previous 10 | Next 10 |
Gainers : Arcadia Biosciences (NASDAQ: RKDA ) +49% . Soliton (NASDAQ: SOLY ) +24% . GTT Communications (NYSE: GTT ) +17% . Everspin Technologies (NASDAQ: MRAM ) +16% . AMAG Pharmaceuticals (NASDAQ: AMAG ) +15% . China SXT Pharmaceuticals (NASDAQ: SXTC ) +15% . TrueCar (NASDAQ: T...
Arcadia Biosciences (NASDAQ: RKDA ) +34% . More news on: Arcadia Biosciences, Inc., ViewRay, Inc., Stocks on the move, Read more ...
Gainers: Arcadia Biosciences (NASDAQ: RKDA ) +123% . Two River Bancorp (NASDAQ: TRCB ) +46% . InnerWorkings (NASDAQ: INWK ) +45% . Cutera (NASDAQ: CUTR ) +30% . PCTEL (NASDAQ: PCTI ) +24% . iFresh (NASDAQ: IFMK ) +21% . Puma Biotechnology (NASDAQ: PBYI ) +20% . China Natural R...
Thinly traded nano cap ViewRay (NASDAQ: VRAY ) is down 52% premarket on increased volume following its Q2 report released after the close yesterday that included softer revenue guidance. Highlights: More news on: ViewRay, Inc., Healthcare stocks news, Stocks on the move, Earn...
ViewRay, Inc. (VRAY) Q2 2019 Earnings Conference Call August 08, 2019, 04:30 PM ET Company Participants Michaella Gallina - Head of IR Scott Drake - President and CEO Shar Matin - COO Jim Alecxih - Chief Commercial Officer Conference Call Participants Anthony Petrone - Je...
ViewRay (NASDAQ: VRAY ): Q2 GAAP EPS of -$0.32 misses by $0.08 . More news on: ViewRay, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
CLEVELAND , Aug. 8, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2019 . Second Quarter 2019 Summary: The Company is updating 2019 guidance and now anticipates total revenue in the range of ...
This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers’ 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers’ regulatory 13F Form filed on 08/05/2019. Please visit our Tracking Kahn Brothers Portfolio series t...
CLEVELAND , July 18, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2019 financial results. ViewRay will hold a conference call to discuss results on Thursday, August 8, 2019 at 4:30 p.m. ET / 1:30...
CLEVELAND , July 16, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of Dr. Gail Wilensky to its Board of Directors, effective today. Dr. Wilensky has an extensive track record in healthcare as a policy leader, reimbursement expert, and board member....
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...